Category: RSV
RSV Is Bad. Where’s the Vaccine?
(WSJ Podcast) Every winter, the respiratory virus RSV lands tens of thousands of babies and young children in hospitals around the country. This year, the outbreak started early. WSJ’s Denise Roland explains the challenges of creating an RSV vaccine.
Nov 15, 2022
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
(Fierce Biotech) Pfizer has had plenty of success in respiratory syncytial virus (RSV) lately, with multiple FDA designations and clinical advancements for its vaccine candidate. But that’s not enough for the pharma giant. Today, the New York-based behemoth is acquiring ReViral and its collection of therapeutics for the pesky respiratory virus for $525 million.
Nov 15, 2022
RSV antibody from Sanofi and AstraZeneca approved in Europe
(Chemical and Engineering News) With the first vaccines to guard against respiratory syncytial virus (RSV) expected to receive regulatory approval in the months ahead, the European Commission earlier this month gave its nod to a monoclonal antibody developed by Sanofi and AstraZeneca to prevent RSV lower respiratory tract illness (LRTI) in newborns and infants. The […]
Nov 15, 2022
RSV hospitalization rate for seniors is 10 times higher than usual for this point in the season
(CNN Video) The respiratory virus season has started early in kids this year and flooded children’s hospitals in many parts of the country – especially with respiratory syncytial virus, known as RSV. But adults can get RSV, too. Although RSV does not typically send as many adults to the hospital, it can be a serious and even deadly […]
Nov 15, 2022
RSV hospitalizations triple in recent weeks in Oregon
(Local News) Oregon Gov. Kate Brown issued an executive order Monday in response to the surge of pediatric cases and hospitalizations of respiratory viruses, including Respiratory Syncytial Virus. Cases of the virus, commonly known as RSV, have been rising across Oregon for the last four weeks. Brown said this executive order will give hospitals more […]
Nov 15, 2022
California child dies of flu and RSV as cases soar, hospitals threatened
(Los Angeles Times) Flu season has roared to life in California, reaching levels not seen in years and threatening to further strain a healthcare system already contending with an onslaught of RSV cases and still-potent circulation of the coronavirus. Underscoring the worrisome conditions, California Department of Public Health officials on Monday reported the season’s first death of […]
Nov 15, 2022
(Lancet) Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants. The burden of RSV infection in healthy term infants has not yet been established. Accurate health-care burden data in healthy infants are necessary to determine RSV immunisation policy when RSV immunisation becomes available.
Nov 11, 2022
Boston: ICU full, kids waiting on treatment as RSV cases overwhelm Boston hospitals
(Local News) Pediatric intensive care units are filled to capacity and many young children are waiting on emergency treatment as hospitals in Boston work to combat a surge in respiratory syncytial virus cases, or RSV, officials said Thursday. They are calling it a ‘capacity disaster’ at Massachusetts General Hospital. The Mass General Brigham hospital system […]
Nov 11, 2022
RSV Hospitalizations Surge, Babies Hit Hardest
(WSJ) Emergency departments, pediatric hospitals are strained by unseasonably early rise in respiratory infections High rates of hospitalization with RSV are hitting the youngest children especially hard, part of an unseasonably early surge in respiratory infections. Some 3.0 people for every 100,000 were hospitalized with respiratory syncytial virus the week ended Nov. 5, according to federal […]
Nov 11, 2022
FDA Fast-Tracks Codagenix RSV Vaccine Candidate
(Contagion Live) Codagenix Inc. announced the US Food and Drug Administration (FDA) recently granted Fast Track designation to CodaVax-RSV, their respiratory syncytial virus (RSV) vaccine candidate. RSV is a common, contagious respiratory virus that attacks the lungs and breathing passageways. There is currently no approved vaccine for RSV, but an ongoing uptick in cases has led to an increased fervor of […]
Nov 7, 2022